Advancements in breast cancer research suggest that some patients might be genetically inclined to respond to, or resist, traditional treatment methods such as chemotherapy, according to the BBC.
The news source reports that the findings could explain why some patients respond to treatment methods that have proven ineffective for others, and could ultimately lead to more custom-care for women who are diagnosed with breast cancer.
"It is too early to say whether this research will lead to a predictive test, but work like this inches us a little closer towards an age of personalized cancer treatment," Oliver Childs, from Cancer Research UK, told the news provider.
The National Breast Cancer Awareness Month suggests that women begin to undergo regular mammography screenings starting at age 40 to ensure early detection of the condition, and obtain a risk assessment from a physician to ascertain their likelihood of developing the disease.
Women who are at a greater risk of breast cancer might opt to undergo more frequent screenings.